Bli medlem
Bli medlem

Du är här


Navamedic ASA: Significantly improved profitability

Navamedic ASA today announced the Company's first quarter 2015 financial
results. Navamedic's profitability improved significantly from last year's
first quarter, while sales increased by 44 per cent.

Navamedic had sales of NOK 61.8 million in the first quarter, compared to NOK
42.9 million last year.

The Company's EBITDA for the quarter was NOK 4.2 million, compared to NOK 2.0
million the first quarter of 2014. Earnings before taxes for the first
quarter this year ended at NOK 1.5 million, against NOK 0.2 million last

All of Navamedic's three segments - Pharma, Medical Nutrition and Consumer
Care - experienced sales growth and improved profitability in the first
quarter. Of the geographical markets, Finland was the growth winner with a
tripling of sales in the first quarter.

For further information, please contact interim CEO Håkan Josephsson,
telephone +46 706 742 533 or CFO Bjørn Lindholt, telephone +47 9300 6601.

Navamedic ASA is a Norwegian pharmaceutical products company, marketing and
distributing more than 120 products in the Nordic and Benelux markets. The
Company operates three business areas; Pharma Products, Medical Nutrition and
Consumer Care based on its relationship with a number of pharmaceutical
product manufacturers. Navamedic is listed on the Oslo Stock Exchange
(ticker: NAVA).


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.